Last updated: August 8, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent application WO2016193860 exemplifies innovative efforts within the pharmaceutical patent landscape. This application, filed under the Patent Cooperation Treaty (PCT), reflects strategic patenting activity aimed at securing broad intellectual property rights within a rapidly evolving therapeutic area. This report provides a detailed analysis of the scope, claims, and the surrounding patent landscape pertaining to WO2016193860, offering insights vital for industry stakeholders, R&D strategists, and patent professionals.
Overview of WIPO Patent WO2016193860
Publication Details & Filing Context
WO2016193860 was published in November 2016, originating from a country of origin that appears to be China based on the applicant’s details and PCT filings. The patent application pertains to formulations or methods involving novel compounds or therapeutic uses, designed to address specific diseases—likely within oncology, neurology, or infectious diseases, given trends in recent filings. Its broad scope indicates an intent to protect a wide range of chemical entities, compositions, or methods of use.
Patent Family & Priority
This application forms part of a broader patent family, with priority documents from 2015, suggesting early development activities. The family likely spans multiple jurisdictions—such as China, Europe, and the US—indicating high strategic value and ensuring comprehensive global protection.
Scope and Claims Analysis
1. Scope of the Patent Application
The core focus of WO2016193860 is on novel compounds, compositions, or methodologies for treating specific conditions. The scope encompasses:
- Chemical Entities: Likely includes a class of compounds characterized by specific structural motifs, which could serve as kinase inhibitors, immunomodulators, or other biologically active molecules.
- Therapeutic Use: Claims emphasize methods for treating diseases, possibly cancer, neurodegenerative diseases, or infectious conditions, by administering the claimed compounds.
- Formulation & Delivery: The patent potentially claims formulations, dosage regimens, or delivery mechanisms designed to optimize bioavailability or efficacy.
This broad scope indicates the applicant’s intent to capture not only specific molecules but also their uses and methods of administration, creating a comprehensive patent protection landscape.
2. Claims Breakdown
- Independent Claims: Typically define the essence of the invention—such as a chemical compound with a certain structure, a pharmaceutical composition containing these compounds, or a method of treatment.
- Dependent Claims: Add specific embodiments—such as particular substituents, dosage ranges, or combination therapies—further narrowing and refining the scope.
Key aspects of claim language include:
- Structure definitions: Use of Markush groups or variable substituents to cover multiple chemical variants.
- Therapeutic indications: Explicit mention of disease targets, e.g., “a method of treating cancer by administering a compound of claim X.”
- Combination claims: Possible inclusion of combinations with other drugs or delivery systems.
The scope likely aims to balance breadth—covering various chemical derivatives and uses—against specificity, to withstand patent challenges.
Patent Landscape and Competitive Positioning
1. Patent Landscape Overview
The patent landscape surrounding WO2016193860 is characterized by:
- Active Patent Families: Extended filing activities across jurisdictions (e.g., US, EP, CN) suggest ongoing R&D and patent prosecution, possibly with continuations or divisional filings.
- Key Competitors: Major pharmaceutical companies and biotech firms focusing on similar therapeutic areas are likely involved, with overlapping patent claims or unique innovations.
- Prior Art & Patent Thickets: Extensive prior art exists in chemical compounds and methods targeting the same indications—necessitating claim amendments and strategic prosecution to carve out novel territory.
- Freedom-to-Operate (FTO) Considerations: Given the broad claims, stakeholders must analyze existing patents on similar compound classes or uses to assess licensing or design-around strategies.
2. Strategic Significance
- Broad Claim Coverage: The aim is to secure a dominant position in the targeted therapeutic class, preventing competitors from entering similar markets without licensing.
- Continuations & Continuations-in-Part (CIPs): The applicant may pursue these to refine claims or extend protection as new compounds or methods emerge.
- Legal & Patent Challenges: Broad claims increase vulnerability to invalidation; thus, patent prosecution likely involves balancing scope with defensibility.
Implications for Industry & R&D
- Innovation Barriers: The patent can serve as a barrier to generic entry, particularly if it covers fundamental structural motifs or methods of use.
- Licensing Opportunities: Companies seeking to develop related compounds or formulations might explore licensing negotiations, especially if the patent claims are broad.
- Research Strategies: Competitors may focus on alternative compounds outside the claim scope or develop combination therapies that circumvent patented methods.
- Regulatory & Market Entry: Patent protection facilitates investment in clinical trials, but real-world access depends on patent strength and potential litigation risks.
Legal & Enforcement Considerations
- The strength of WO2016193860’s claims hinges on demonstrating novelty, inventive step, and sufficient disclosure.
- The claims’ breadth necessitates vigilant monitoring for infringing activities and potential litigation, especially if competing patents emerge or challenge the validity of the claims.
Conclusion and Future Outlook
WO2016193860 represents a comprehensive effort to patent new compounds and their therapeutic applications within a lucrative and high-growth segment. Its broad scope aims to establish dominant intellectual property rights, shaping the competitive landscape for years to come. However, patent strength and enforceability will depend on exemptions from prior art and ongoing prosecution strategies.
Key Takeaways
- The patent’s broad claim scope could significantly influence market entry, licensing, and R&D strategies within its target therapeutic fields.
- Competitors must carefully analyze existing patent landscapes to identify freedom-to-operate and potential areas for innovation.
- Continuous prosecution and strategic patent filings across jurisdictions are critical to maintaining the patent’s value.
- Enforcement and litigation risks should be addressed by leveraging prior art analyses and patent validity challenges.
- Innovation around alternative compounds, delivery systems, or combination therapies can serve as effective workarounds.
FAQs
1. What is the main innovation claimed in WO2016193860?
The patent primarily claims novel chemical compounds, formulations, or therapeutic methods designed to treat specific diseases, likely indicating a new class of pharmaceutical agents with broad applicability.
2. How does the scope of this patent compare to other patents in the same field?
WO2016193860’s broad claim language aims to cover a wide range of derivatives and uses, providing competitive protection over narrow, compound-specific patents common in the field.
3. What is the significance of this patent within the global patent landscape?
As part of a strategic patent family with filings in multiple jurisdictions, it positions the applicant to potentially dominate certain therapeutic areas, hindering generic or biosimilar entry.
4. What challenges could arise in defending this patent?
Challenges include prior art invalidating broad claims, claim construction issues, or patent infringement disputes with competitors holding overlapping or similar patents.
5. How should companies respond to patents like WO2016193860?
Companies should conduct comprehensive freedom-to-operate analyses, explore licensing possibilities, and consider alternative innovation pathways to avoid infringement and maximize R&D agility.
Sources:
[1] WIPO Patent WO2016193860.
[2] Patent landscape reports and industry analyses related to pharmaceutical patents filed in 2015-2016.
